Clinical Trial Update: Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1a study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of RN5681 in healthy volunteers. The trial targets individuals with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• RN5681

Snippet

Sponsor: Ikaria Bioscience Pty Ltd | Conditions: High Cholesterol | Phase 1 | Status: RECRUITING